Health Research, Vol. 3, Issue 3, Sep  2019, Pages 23-31; DOI: 10.31058/j.hr.2019.33003 10.31058/j.hr.2019.33003

Examining Cancer Prevalence in Africa

Health Research, Vol. 3, Issue 3, Sep  2019, Pages 23-31.

DOI: 10.31058/j.hr.2019.33003

İLker Etikan 1* , Ogunjesa Babatope 1

1 İlker Etikan

1 Ogunjesa Babatope

Received: 10 November 2019; Accepted: 26 November 2019; Published: 30 November 2019

Full-Text HTML | Download PDF | Views 34 | Download 20

Abstract

Cancer is one of the major contributors to the global disease burden with a devastating effect on the socio-economic status of any nation. In Africa countries, the rising number of new cases of cancer and the geographical disproportionate pattern has become a challenge to the continent’s public healthcare system. Thus, the study seeks to investigate the trend of cancer on the continent by reviewing previous works of literature and by examining the challenges surrounding the scourge of this disease. Inference from the study shows that for effective combat against cancer, different countries on the continent need to commit sufficient resources to cancer care and encourage early screening procedures in order to reduce the late presentation of the diseases which is often the case in many African countries.

Keywords

Africa, Cancer, Carcinogen, Mortality, Non-Communicable Diseases, Survival

Copyright

© 2017 by the authors. Licensee International Technology and Science Press Limited. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

[1] World Health Organization (WHO).Non-communicable diseases. Available on https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases (accessed on 8 May 2019).
[2] Blackadar, Clarke Brian. Historical review of the causes of cancer. World J Clin Oncol, 2016, 7(1), 54-86.
[3] Williams, M.J.; Werner, B.; Heide, T. et al. Quantification of subclonal selection in cancer from bulk sequencing data. Nat Genet. 2018, 50, 895-903.
[4] Oliveira DeilsonElgui de. DNA viruses in human cancer: An integrated overview of fundamental mechanisms of viral carcinogenesis. Cancer Letters. 2009, 247(2), 182-196.
[5] Arbyn M.; Castellsague X.; De Sanjose S.; Bruni L.; Saraiya M.; Bray F.; et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011, 22 (12), 2675-2686.
[6] Bray F.; Jemal A.; Grey N.; Ferlay J.; Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 2012, 13, 790-801.
[7] Ferlay J.; Shin H.R.; Bray F.; Forman D.; Mathers C.; Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010, 127(12), 2893-917.
[8] International Agency for Research on Cancer. Globacon 2018: estimated cancer incidence, mortality, and prevalence worldwide in 2018. Available on https://gco.iarc.fr/today/home (accessed on 8 May 2019).
[9] World Population Review. 2019 World Population by Country. Available on http://worldpopulationreview.com/ (accessed on the 8 May 2019).
[10] Fregene A.; Newman L.A. Breast cancer in sub-Saharan Africa: How does it relate to breast cancer in African-American women? Cancer. 2005, 103, 1540-50.
[11] Gordon L.; Scuffham P.; Hayes S.; Newman B. Exploring the economic impact of breast cancers during the 18 months following diagnosis. Psycho-Oncol. 2007, 16(12), 1130-9.
[12] .The National Academies Press. The consequences of maternal morbidity and maternal mortality: report of a workshop. 2000. [cited]; Available on: http://www.nap.edu/read/9800/chapter/2 (accessed on the 8 May 2019).
[13] International Agency for Research on Cancer. Globacon 2012: estimated cancer incidence, mortality, and prevalence worldwide in 2012. Available on http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (Accessed on 8 May 2019).
[14] De Martel C.; Ferlay J.; Franceschi S.; et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012, 13, 607-15.
[15] Walboomers J.M.; Jacobs M.V.; Manos M.M.; et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189, 12-9.
[16] Lowy, D.; Solomon, D.; Hildesheim, A.; Schiller, J.T.; Schiffman, M. Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer. 2008, 113, S1980-S1993.
[17] Finnochiario-Kessler, S.; Wexler, C.; Maloba, M.; Mabachi, N.; Ndikum-Moffor, F.; Bukus, E. Cervical cancer prevention and treatment research in Africa: A systematic review from a public health perspective. BMC Womens Health, 2016, 4, 16-29.
[18] Gallagher K.E.; Erio T.; Baisley K.; Lees S.; Watson-Jones D. The impact of a human papillomavirus (HPV) vaccination campaign on routine primary health service provision and health workers in Tanzania: a controlled before and after study. BMC Health Serv. Res. 2018, 18 (1), 1-10.
[19] Ndejjo, R.; Mukama, T.; Musabyimana, A.; Musoke, D. Uptake of cervical cancer screening and associated factors among women in rural Uganda: A cross-sectional study. PLoS ONE, 2016, 19, 11(2), e0149696.
[20] .Hsing A.W.; S.S. Devesa. Trends and patterns of prostate cancer: what do they suggest? Epidemiol. Rev. 2001, 23(1), 3-13.
[21] Hsing A.W.; L. Tsao; S.S. Devesa. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer. 2000, 85(1), 60-67.
[22] Parkin D.M.; J. Ferlay; M. Hamdi-Cherif et al. Cancer in Africa: Epidemiology and Prevention, IARC Scientific Publications, Lyon, France, 2003. Available on https://publications.iarc.fr/Book-And-Report-Series/Iarc-Scientific-Publications/Cancer-In-Africa-Epidemiology-And-Prevention-2003 (accessed on 8 May 2019).
[23] Rudan I.; Campbell H.; Marušić A.; Sridhar D.; Nair H.; Adeloye D.; Theodoratou E.; Chan K.Y. Assembling GHERG: Could “academic crowdsourcing” address gaps in global health estimates? J. Glob. Health. 2015, 5(1).
[24] Odedina F.T.; Akinremi T.O.; Chinegwundoh F.; Roberts R.; Yu D.; Reams R.R.; Freedman M.L.; Rivers B.; Green B.L.; Kumar N. Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer. 2009, 4, Suppl 1: S2.
[25] Gondos A.; Brenner H.; Wabinga H.; Parkin D.M. Cancer survival in Kampala, Uganda. Br J Cancer. 2005, 92, 1808-12.
[26] .Azubuike Samuel O.; Muirhead Colin; Hayes Louise; McNally Richard. Rising global burden of breast cancer: the case of sub-Saharan Africa (with emphasis on Nigeria) and implications for regional development: a review. World J Surg Oncol. 2018, 16, 63.